Titan Medical (NASDAQ:TMDIF – Get Free Report) and Integra LifeSciences (NASDAQ:IART – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, institutional ownership and profitability.
Profitability
This table compares Titan Medical and Integra LifeSciences’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Titan Medical | N/A | -82.31% | -51.47% |
Integra LifeSciences | -0.42% | 12.35% | 4.82% |
Volatility and Risk
Titan Medical has a beta of 1.26, meaning that its stock price is 26% more volatile than the S&P 500. Comparatively, Integra LifeSciences has a beta of 1.15, meaning that its stock price is 15% more volatile than the S&P 500.
Valuation and Earnings
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Titan Medical | $17.63 million | 2.59 | $6.95 million | $0.05 | 8.00 |
Integra LifeSciences | $1.56 billion | 1.07 | $67.74 million | ($0.09) | -242.22 |
Integra LifeSciences has higher revenue and earnings than Titan Medical. Integra LifeSciences is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of recent ratings for Titan Medical and Integra LifeSciences, as reported by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Titan Medical | 0 | 0 | 0 | 0 | 0.00 |
Integra LifeSciences | 3 | 4 | 1 | 0 | 1.75 |
Integra LifeSciences has a consensus target price of $23.00, indicating a potential upside of 5.50%. Given Integra LifeSciences’ stronger consensus rating and higher probable upside, analysts clearly believe Integra LifeSciences is more favorable than Titan Medical.
Institutional & Insider Ownership
0.0% of Titan Medical shares are owned by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are owned by institutional investors. 0.0% of Titan Medical shares are owned by insiders. Comparatively, 3.1% of Integra LifeSciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Summary
Integra LifeSciences beats Titan Medical on 9 of the 14 factors compared between the two stocks.
About Titan Medical
Titan Medical Inc. operates as a medical technology company. It focuses on the development and licensing of robotic assisted surgical technologies. The company is headquartered in Toronto, Canada.
About Integra LifeSciences
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
Receive News & Ratings for Titan Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Titan Medical and related companies with MarketBeat.com's FREE daily email newsletter.